AGI

Welcome to the Brand page for “AGI”, which is offered here for In the statement, column 1, lines 4 - column 2, line 4, are deleted, and, medical diagnostic and prescription pharmaceutical preparations for the treatment of rheumatoid and pulmonary inflammatory and cardiovascular diseases, angina, asthma, atherosclerosis, coronary artery diseases, ischemia, post-angioplasty restenosis, proliferative disorders of smooth muscle cells and rheumatoid arthritis is inserted.;[diagnostic and pharmaceutical products for the treatment of inflammatory and cardiovascular diseases, alzheimer's disease, angina, asthma, atherosclerosis, atopic dermatitis, coronary artery diseases, eczematous dermatitis, endometriosis, ischemia, post-angioplasty restenosis, pre-eclampsia, proliferative disorders of smooth muscle cells, psoriasis, rheumatoid arthritis, and skin cancer] *medical diagnostic and prescription pharmaceutical preparations for the treatment of rheumatoid and pulmonary inflammatory and cardiovascular diseases, angina, asthma, atherosclerosis, coronary artery diseases, ischemia, post-angioplasty restenosis, proliferative disorders of smooth muscle cells and rheumatoid arthritis*;.

Its status is currently believed to be active. Its class is unavailable. “AGI” is believed to be currently owned by “AtheroGenics, Inc.”